Find a Trial

Trial Summary


Protocol No.CTO-BRE18-334
StatusSUSPENDED
Principal InvestigatorSchneider, Bryan
ScopeNational
PhasePhase II
Age GroupAdult
TitleA Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
Applicable Disease SitesBreast
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu